Elutia (ELUT) Shares Outstanding (Diluted Average) (2020 - 2024)
Elutia recorded quarterly Shares Outstanding (Diluted Average) of $24.9 million in Q2 2024, up 4.13% quarter-over-quarter from $23.9 million in Q1 2024, and up 53.48% year-over-year from $16.2 million in Q3 2023.
Elutia's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $24.9 million for Q2 2024.
- In Q2 2024, Shares Outstanding (Diluted Average) rose 53.48% year-over-year to $24.9 million; the TTM figure through Jun 2024 stood at $24.9 million (up 53.48% YoY), while the FY2023 annual figure was $18.2 million, up 31.29% from the prior year.
- Shares Outstanding (Diluted Average) came in at $24.9 million for Q2 2024 at Elutia, up from $23.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $24.9 million in Q2 2024 to a low of $648277.0 in Q2 2020.
- A 5-year average of $12.7 million and a median of $13.6 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- Across the five-year window, Shares Outstanding (Diluted Average) soared 1477.89% in 2021 and advanced 18.97% in 2023, its largest moves.
- Elutia's Shares Outstanding (Diluted Average) stood at $2.9 million in 2020, then soared by 266.16% to $10.4 million in 2021, then soared by 32.44% to $13.8 million in 2022, then soared by 31.29% to $18.2 million in 2023, then surged by 37.11% to $24.9 million in 2024.
- According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $24.9 million, $23.9 million, and $18.2 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 24.90 Mn |
| Mar 31, 2024 | 23.91 Mn |
| Dec 31, 2023 | 18.16 Mn |
| Sep 30, 2023 | 17.02 Mn |
| Jun 30, 2023 | 16.21 Mn |
| Mar 31, 2023 | 16.15 Mn |
| Dec 31, 2022 | 13.83 Mn |
| Sep 30, 2022 | 13.66 Mn |
| Jun 30, 2022 | 13.62 Mn |
| Mar 31, 2022 | 13.57 Mn |
| Dec 31, 2021 | 10.44 Mn |
| Sep 30, 2021 | 10.23 Mn |
| Jun 30, 2021 | 10.23 Mn |
| Mar 31, 2021 | 10.23 Mn |
| Dec 31, 2020 | 2.85 Mn |
| Sep 30, 2020 | 648,331.00 |
| Jun 30, 2020 | 648,277.00 |